Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
- DOI
- 10.1089/nat.2024.0072
- Published
- 2025-02-01
- Container
- Nucleic Acid Therapeutics
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1089/nat.2024.0072,
title = {Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations},
author = {Patrik Andersson and Sebastien A. Burel and Heather Estrella and Jeffrey Foy and Peter H. Hagedorn and Tod A. Harper and Scott P. Henry and Jean-Christophe Hoflack and Erle M. Holgersen and Arthur A. Levin and Eliot Morrison and Adam Pavlicek and Luca Penso-Dolfin and Utsav Saxena},
year = {2025},
journal = {Nucleic Acid Therapeutics},
doi = {10.1089/nat.2024.0072},
url = {https://doi.org/10.1089/nat.2024.0072}
}RIS
TY - JOUR TI - Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations AU - Patrik Andersson AU - Sebastien A. Burel AU - Heather Estrella AU - Jeffrey Foy AU - Peter H. Hagedorn AU - Tod A. Harper AU - Scott P. Henry AU - Jean-Christophe Hoflack AU - Erle M. Holgersen AU - Arthur A. Levin AU - Eliot Morrison AU - Adam Pavlicek AU - Luca Penso-Dolfin AU - Utsav Saxena PY - 2025 JO - Nucleic Acid Therapeutics DO - 10.1089/nat.2024.0072 UR - https://doi.org/10.1089/nat.2024.0072 ER -
APA
Andersson, P., Burel, S. A., Estrella, H., Foy, J., Hagedorn, P. H., Harper, T. A., Henry, S. P., Hoflack, J., Holgersen, E. M., Levin, A. A., Morrison, E., Pavlicek, A., Penso-Dolfin, L., & Saxena, U. (2025). Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2024.0072
Source records
- crossref · retrieved 2026-09-26T17:30:47.626Z